SWOG S2001

Primary Category:

Treatment Protocols

Disease Category:

Pancreatic, Pancreatic Metastatic

Status:

New, Open

Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations

NCT#04548752